Zosano Pharma

NASDAQ ZSAN
- - -%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.27M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

-3.37M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

3.50
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

4.25M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events Zosano Pharma

All events
No upcoming events scheduled

Stock chart Zosano Pharma

Stock analysis Zosano Pharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.02 52.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.04 17.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.06 38.63
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.08 0.81
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-392.74 18.00

Price change Zosano Pharma per year

0.33$ 1.91$
Min Max

Summary analysis Zosano Pharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Zosano Pharma

Revenue and net income Zosano Pharma

All parameters

Stock news Zosano Pharma

All news

Bankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of Claims

Bankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of Claims

Zosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSAN

Zosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSAN

Cash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSAN

Cash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSAN

Zosano Pharma Shares Fall 17%, Warns of Needing 'Substantial Additional Funding'

Zosano Pharma Shares Fall 17%, Warns of Needing 'Substantial Additional Funding'

Zosano Pharma to Lay Off an Additional 40%, Suspends M207 Program

Zosano Pharma to Lay Off an Additional 40%, Suspends M207 Program

Zosano Pharma Shares Tumble Premarket on Public Offering >ZSAN

Zosano Pharma Shares Tumble Premarket on Public Offering >ZSAN

Zosano Pharma Shares Rise 13% on Covid-19 Vaccine Candidate

Zosano Pharma Shares Rise 13% on Covid-19 Vaccine Candidate

Zosano Pharma Sees Successful Formulation of Covid-19 Vaccine Candidate

Zosano Pharma Sees Successful Formulation of Covid-19 Vaccine Candidate

About company Zosano Pharma

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Address:
34790 Ardentech Court, Fremont, CA, United States, 94555
Company name: Zosano Pharma
Issuer ticker: ZSAN
ISIN: US98979H2022
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2015-01-27
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.zosanopharma.com

On which stock exchange are Zosano Pharma (ZSAN) stocks traded?

Zosano Pharma (ZSAN) stocks are traded on NASDAQ.

What is the ticker of Zosano Pharma stocks (ZSAN)?

The stock ticker of Zosano Pharma’s stocks or in other words, the code is ZSAN. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Zosano Pharma (ZSAN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Zosano Pharma (ZSAN) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are Zosano Pharma (ZSAN) stocks traded?

Zosano Pharma (ZSAN) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Zosano Pharma (ZSAN) stocks today?

The current price of Zosano Pharma stocks on 13.05.2024 is dollars. per share.

What is the dynamics of Zosano Pharma (ZSAN) stocks from the beginning of the year?

Zosano Pharma (ZSAN) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Zosano Pharma (ZSAN) stocks increase in мае 2024?

This month Zosano Pharma (ZSAN) quotes have increased by 0% to dollars. per share.

How much are Zosano Pharma (ZSAN) stocks worth?

Today, on October, 13.05.2024 Zosano Pharma’s (ZSAN) stocks cost dollars..

What is the market capitalization of Zosano Pharma (ZSAN)?

Capitalization is the market value of Zosano Pharma (ZSAN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 13.05.2024, the market capitalization of Zosano Pharma (ZSAN) is estimated at about 1274400 dollars.